AUSTIN: Discontinuing statin use in patients with late-stage cancer and other terminal illnesses may help improve patients’ quality of life without causing other adverse health effects, according to a new study led by researchers at the University of Colorado Anschutz Medical Campus and Duke University and funded by the National Institute of Nursing Research (NINR).
The finding indicates that care for patients with advanced illness can be improved by discontinuing some therapies that are primarily preventive for other health concerns…